Table 5. Multivariate analysis of PFS and OS for all LAC patients.
| PFS | OS | |||||
|---|---|---|---|---|---|---|
| 95%CI | HR | P value | 95%CI | HR | P value | |
| Lesion type(central, peripheral) | 0.884-1.790 | 1.258 | 0.203 | 0.886-1.788 | 1.259 | 0.199 |
| pTNM status(I+II,III+IV) | 2.121-4.838 | 3.203 | <0.001 | 2.260-5.516 | 3.414 | <0.001 |
| Serum CEA(≤5 ng/mL, >5 ng/mL) | 0.866-1.818 | 1.254 | 0.231 | 0.814-1.714 | 1.181 | 0.381 |
| E-cadherin(negative, positive) | 0.606-1.304 | 0.889 | 0.548 | 0.591-1.264 | 0.864 | 0.452 |
| Cripto-1(low, high) | 1.295-2.862 | 1.925 | 0.001 | 1.290-2.833 | 1.912 | 0.001 |
PFS progression-free survival, OS overall survival, CI confidential interval, HR hazard ratio.